The Medicinal Chemistry of Glucocorticoid Receptor Modulators

This book covers the design and development of glucocorticoid receptor modulators (GRM) from cortisol to antibody-drug conjugate payloads over the last 70 years. The author starts with an introduction to the background of glucocorticoid receptor modulators as potential therapeutic modalities. This i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Hobson, Adrian (Autor)
Autor Corporativo: SpringerLink (Online service)
Formato: Electrónico eBook
Lenguaje:inglés
Publicado: Cham : Springer Nature Switzerland : Imprint: Springer, 2023.
Edición:1st ed. 2023.
Colección:SpringerBriefs in Molecular Science,
Materias:
Acceso en línea:https://doi.org/10.1007/978-3-031-28732-9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

MARC

LEADER 00000nam a22000005i 4500
001 978-3-031-28732-9
003 DE-He213
005 20260810115144.0
007 cr nn 008mamaa
008 230411s2023 sz | o |||| 0|eng d
020 |a 9783031287329  |9 978-3-031-28732-9 
024 7 |a 10.1007/978-3-031-28732-9  |2 doi 
050 4 |a RS400-431 
072 7 |a PNN  |2 bicssc 
072 7 |a PSB  |2 bicssc 
072 7 |a SCI013020  |2 bisacsh 
072 7 |a PNB  |2 thema 
082 0 4 |a 615.19  |2 23 
100 1 |a Hobson, Adrian.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 4 |a The Medicinal Chemistry of Glucocorticoid Receptor Modulators  |h [electronic resource] /  |c by Adrian Hobson. 
250 |a 1st ed. 2023. 
264 1 |a Cham :  |b Springer Nature Switzerland :  |b Imprint: Springer,  |c 2023. 
300 |a 1 online resource (IX, 142 p. 172 illus.). 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
341 0 |b Table of contents navigation  |2 onix 
341 0 |b Single logical reading order  |2 onix 
341 0 |b Short alternative textual descriptions  |2 onix 
341 0 |b Use of color is not sole means of conveying information  |2 onix 
341 0 |b Use of high contrast between text and background color  |2 onix 
341 0 |b Next / Previous structural navigation  |2 onix 
341 0 |b All non-decorative content supports reading without sight  |2 onix 
347 |a text file  |b PDF  |2 rda 
490 1 |a SpringerBriefs in Molecular Science,  |x 2191-5415 
505 0 |a Introduction -- cortisol-based glucocorticoids -- metabolically inactivated glucocorticoids -- prodrugs -- selective glucocorticoid receptor modulators -- polymers and particles -- QSAR and Modelling -- Antibody Drug Conjugates -- Conclusion. 
520 |a This book covers the design and development of glucocorticoid receptor modulators (GRM) from cortisol to antibody-drug conjugate payloads over the last 70 years. The author starts with an introduction to the background of glucocorticoid receptor modulators as potential therapeutic modalities. This is followed by seven chapters in which he collates and discusses the medicinal chemistry journey of GRMs, reviewing topics such as cortisol-based glucocorticoids, the different approaches that have been pursued to enable chronic dosing of GRM compounds by inactivation in plasma and the liver, the application of prodrugs to GRMs, selective GRMs, targeted delivery of GRMs using polymers and nanoparticles, and rational drug design approaches applied in the development of GRMs. Particular attention is given to the development of glucocorticoid receptor modulators as immunology antibody-drug conjugate payloads. In the book’s final chapter, the author critiques the medicinal chemistry progress madesince the discovery of cortisone and the promise of the latest antibody-drug conjugates that release a GRM payload. In this book, readers will also find an overview of the X-ray structures of glucocorticoid receptor antagonists and a list of all the earlier reviews that cover part of the medicinal chemistry story of GRM collated by keywords organized in a table. With several examples of crystal structures and molecular modeling, this book illustrates the huge effort by multiple companies and research groups to develop glucocorticoid receptor modulators. Professionals and scholars alike will find it a handy tool, and appreciate the latest research findings that it presents. 
532 8 |a Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. 
532 8 |a No reading system accessibility options actively disabled 
532 8 |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com 
588 |a Print version record. 
650 0 |a Medicinal chemistry. 
650 0 |a Pharmaceutical chemistry. 
650 0 |a Drugs  |x Design. 
650 0 |a Chemistry  |x Data processing. 
650 0 |a Chemistry  |x History. 
650 1 4 |a Medicinal Chemistry. 
650 2 4 |a Pharmaceutics. 
650 2 4 |a Structure-Based Drug Design. 
650 2 4 |a Computational Chemistry. 
650 2 4 |a History of Chemistry. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783031287312 
776 0 8 |i Printed edition:  |z 9783031287336 
830 0 |a SpringerBriefs in Molecular Science,  |x 2191-5415 
856 4 0 |u https://doi.org/10.1007/978-3-031-28732-9 
912 |a ZDB-2-CMS 
912 |a ZDB-2-SXC 
950 |a Chemistry and Materials Science (SpringerNature-11644) 
950 |a Chemistry and Material Science (R0) (SpringerNature-43709)